ImageneBio, Inc. Common Stock (IMA) Stock Price

IMAStock

$5.55−60.51%52W

Market Cap$63.13M

P/E—

PEG Ratio—

Div yield—

Beta0.74

IMA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-25.31%

Price vs S&P 500 (4W)-5.48%

VGM Score20.08

Book Value / Share (Quarterly)$10.93

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-62.86%

Cash Flow / Share (Quarterly)$-4.62

Price vs S&P 500 (YTD)-30.51%

Net Profit Margin (TTM)-744.28%

EPS (TTM)$-5.40

10-Day Avg Trading Volume0.01M

EPS Excl Extra (TTM)$-5.40

Revenue Growth (5Y)-38.63%

EPS (Annual)$-9.31

ROI (Annual)-34.06%

Net Profit Margin (5Y Avg)-1488.95%

Cash / Share (Quarterly)$10.39

ROA (Last FY)-29.64%

EBITD / Share (TTM)$-6.99

ROE (5Y Avg)-35.30%

Operating Margin (TTM)-823.43%

Cash Flow / Share (Annual)$-4.28

P/B Ratio0.54x

P/B Ratio (Quarterly)0.43x

Net Income / Employee (Annual)$-3,023,300

ROA (TTM)-31.26%

EPS Incl Extra (Annual)$-9.31

Current Ratio (Annual)12.49x

Quick Ratio (Quarterly)17.67x

3-Month Avg Trading Volume0.03M

52-Week Price Return-60.51%

Revenue / Employee (TTM)$0

P/S Ratio (Annual)83.29x

Asset Turnover (Annual)0.01x

52-Week High$14.34

Operating Margin (5Y Avg)-1585.64%

EPS Excl Extra (Annual)$-9.31

26-Week Price Return-14.07%

Quick Ratio (Annual)12.16x

13-Week Price Return1.81%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)18.39x

Enterprise Value$-9.41M

Revenue / Share Growth (5Y)-9.18%

Asset Turnover (TTM)0.05x

Revenue / Employee (Annual)$53,300

Pretax Margin (Annual)-5712.37%

Cash / Share (Annual)$12.10

3-Month Return Std Dev48.95%

Net Income / Employee (TTM)$-3,004,900

ROE (Last FY)-34.06%

EPS Basic Excl Extra (Annual)$-9.31

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-5.40

ROI (TTM)-35.20%

P/S Ratio (TTM)7.28x

Pretax Margin (5Y Avg)-1498.06%

Revenue / Share (Annual)$0.16

Price vs S&P 500 (52W)-78.82%

Year-to-Date Return-18.55%

5-Day Price Return-1.06%

EPS Normalized (Annual)$-9.31

ROA (5Y Avg)-30.72%

Net Profit Margin (Annual)-5668.62%

Month-to-Date Return1.44%

EBITD / Share (Annual)$-9.87

Operating Margin (Annual)-6056.37%

ROI (5Y Avg)-35.30%

EPS Basic Excl Extra (TTM)$-5.40

P/B Ratio (Annual)0.61x

Pretax Margin (TTM)-746.05%

Book Value / Share (Annual)$11.91

Price vs S&P 500 (13W)-0.98%

Beta0.74x

P/FCF (Annual)1.40x

Revenue / Share (TTM)$0.00

ROE (TTM)-35.20%

52-Week Low$3.94

gGradeF

mGradeD

vgmGradeD

IMA Earnings Surprise History

Q2 25-4.46est. —

Q3 25-2.91est. -1.00

Q1 26-0.95est. -0.66

Q2 26-0.63est. -0.98

IMA Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.86

Industry Peers — Biological Products(183)

Symbol	Value Score	Growth Score	Momentum Score	Price
IMAImageneBio, Inc. Common Stock	—	F	D	$5.55
AMGNAmgen Inc	C	C	B	$442.24
GILDGilead Sciences Inc	C	B	B	$148.77
MRNAModerna, Inc. Common Stock	D	C	A	$158.83
ARGXargenx SE American Depositary Shares	D	A	B	$1019.49
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$211.38
BIIBBiogen Inc. Common Stock	C	D	B	$220.77
BNTXBioNTech SE American Depositary Share	C	C	B	$114.05
NBIXNeurocrine Biosciences Inc	C	B	C	$153.37
EXELExelixis Inc	C	B	B	$56.72
HALOHalozyme Therapeutics, Inc.	C	B	A	$109.32
TECHBio-Techne Corp.	D	C	B	$72.33
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	$356.19
KYMRKymera Therapeutics, Inc. Common Stock	D	B	B	$126.64
RGENRepligen Corp	D	C	A	$181.69
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	$134.85
TWSTTwist Bioscience Corporation Common Stock	D	B	A	$151.42
PCVXVaxcyte, Inc. Common Stock	—	—	B	$61.09
QGENQIAGEN N.V.	C	C	C	$43.65
IMVTImmunovant, Inc. Common Stock	—	—	B	$43.50
IBRXImmunityBio, Inc. Common Stock	F	A	C	$8.19
SRRKScholar Rock Holding Corporation Common Stock	F	—	B	$58.25
CGONCG Oncology, Inc. Common stock	F	A	A	$78.95
CRSPCRISPR Therapeutics AG	D	B	B	$60.90
RLAYRelay Therapeutics, Inc. Common Stock	F	D	A	$20.57
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	A	$26.25
DNLIDenali Therapeutics Inc. Common Stock	F	—	B	$24.93
IOVAIovance Biotherapeutics, Inc. Common Stock	C	B	A	$8.44
BEAMBeam Therapeutics Inc. Common Stock	C	B	B	$31.03
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	$71.45
BCRXBioCryst Pharmaceuticals Inc	B	A	B	$9.83
KODKodiak Sciences Inc Common Stock	—	—	B	$39.46
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	B	$49.65
MESOMesoblast Limited American Depositary Shares	D	B	C	$17.19
VCELVericel Corporation	D	B	C	$43.22
ADMAADMA Biologics, Inc.	C	C	C	$9.72
TSHATaysha Gene Therapies, Inc. Common Stock	F	B	B	$6.20
IMCRImmunocore Holdings plc American Depositary Shares	D	B	B	$37.40
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	$3.56
VIRVir Biotechnology, Inc. Common Stock	B	B	B	$10.71
INBXInhibrx Biosciences, Inc. Common Stock	D	C	B	$122.72
ALVOAlvotech Ordinary Shares	C	D	B	$5.05
MAZEMaze Therapeutics, Inc. Common Stock	—	—	B	$30.42
NVAXNovavax Inc	B	D	C	$9.44
REPLReplimune Group, Inc.	—	—	A	$15.80
SLBTSL Science Holding Limited Ordinary Shares	—	—	F	$2.64
MGTXMeiraGTx Holdings plc Ordinary Shares	D	C	A	$14.92
VORVor Biopharma Inc. Common Stock	—	—	B	$24.01
CGEMCullinan Therapeutics, Inc. Common Stock	—	—	A	$22.95
IMTXImmatics N.V. Ordinary Shares	C	D	C	$9.24
ODTXOdyssey Therapeutics, Inc. Common Stock	—	C	A	$26.23

About ImageneBio, Inc. Common Stock

ImageneBio is a clinical-stage biopharmaceutical company developing treatments for immunological and inflammatory diseases. Its lead candidate, IMG-007, is a non-depleting anti-OX40 monoclonal antibody being evaluated for atopic dermatitis.